[1]周 博,杨言通,王公平,等.前哨淋巴结导航技术在老年早期胃窦部腺癌手术中的应用价值[J].新乡医学院学报,2017,34(4):316-319.[doi:10.7683/xxyxyxb.2017.04.019]
 ZHOU Bo,YANG Yan-tong,WANG Gong-ping,et al.Value of sentinel lymph node navigation in the operation of elderly patients with early gastric antral adenocarcinoma[J].Journal of Xinxiang Medical University,2017,34(4):316-319.[doi:10.7683/xxyxyxb.2017.04.019]
点击复制

前哨淋巴结导航技术在老年早期胃窦部腺癌手术中的应用价值
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
34
期数:
2017年4
页码:
316-319
栏目:
临床研究
出版日期:
2017-04-05

文章信息/Info

Title:
Value of sentinel lymph node navigation in the operation of elderly patients with early gastric antral adenocarcinoma
作者:
周 博杨言通王公平陈 晔冯笑山
(河南科技大学临床医学院 河南科技大学第一附属医院胃肠肿瘤外科,河南 洛阳 471003)
Author(s):
ZHOU BoYANG Yan-tongWANG Gong-pingCHEN YeFENG Xiao-shan
(Department of Gastrointestinal Oncological Surgery,the First Affiliated Hospital of Henan University of Science and Technology;Clinical Medical College of Henan University of Science and Technology,Luoyang 471003,Henan Province,China)
关键词:
前哨淋巴结胃癌专利蓝胃大部切除术
Keywords:
sentinel lymph nodegastric carcinomapatent bluesubtotal gastrectomy
分类号:
R735.2
DOI:
10.7683/xxyxyxb.2017.04.019
文献标志码:
A
摘要:
目的 探讨老年早期胃窦部腺癌患者手术中采用专利蓝示踪前哨淋巴结(SLN)预测胃周淋巴结转移状态的临床价值。方法 选择2014年6月至2016年6月河南科技大学第一附属医院收治的老年早期胃窦部腺癌患者48例,所有患者行远端胃大部切除术,手术时,先将专利蓝液(1∶1稀释)注射于肿瘤周围浆膜下,找到最先染色的胃周SLN,然后行D2根治术,术后将SLN及其余各组淋巴结进行病理检查,评估胃周淋巴结转移状态。结果 48例患者中,46例患者通过术中专利蓝示踪检出SLN,检出率为95.8%(46/48)。应用专利蓝示踪SLN状态来预测老年早期胃窦部腺癌患者胃周淋巴结转移的准确性为91.3%(42/46),敏感性为80.0%(16/20),特异性为100.0%(26/26),假阴性率为11.1%(2/18)。SLN转移阳性率、检出率、准确性、敏感性及假阴性率与患者性别无显著相关性(P>0.05);SLN转移阳性率与肿瘤浸润深度有显著相关性(P<0.01),而SLN检出率、准确性、敏感性及假阴性率与肿瘤浸润深度无显著相关性(P>0.05)。结论 老年早期胃癌患者手术时使用专利蓝进行SLN示踪可以较为准确地判断胃周淋巴结转移情况。
Abstract:
Objective To investigate the clinical value of patent blue tracing sentinel lymph node (SLN) in predicting the lymph node metastasis in elderly patients with early gastric antral adenocarcinoma.Methods Forty-eight patients with early early gastric antral adenocarcinoma who underwent distal subtotal gastrectomy in the First Affiliated Hospital of Henan University of Science and Technology from June 2014 to June 2016 were selected.During the operation,the patent blue liquid (1∶1 dilution) was injected into the serous membrane around the tumor to find the stained gastric SLN,and then the D2 radical operation was performed.The SLN and other lymph nodes were performed with pathological examination to evaluate the status of lymph node metastasis.Results In the 48 cases,SLN was detected by intraoperative patent blue tracer in 46 patients,the detection rate of SLN was 95.8%(46/48).The accuracy,sensitivity,specificity and false negative rate of patent blue tracing SLN to predict the lymph node metastasis in elderly patients with early gastric adenocarcinoma was 91.3% (42/46),80.0%(16/20),100.0%(26/26) and 11.1%(2/18) respectively.The SLN metastasis positive rate,detection rate,accuracy,sensitivity and false negative rate were unrelated to the gender of the patients (P>0.05).The SLN metastasis positive rate was significantly correlated with the tumor invasion (P<0.01);but the detection rate,accuracy,sensitivity and false negative rate were unrelated to the tumor invasion(P>0.05).Conclusion Using patent blue to track SLN can accurately evaluate the status of perigastric lymph node metastasis in the operation of the elderly patients with early gastric antral adenocarcinoma.

参考文献/References:

[1] SHIRAISHI N,YASUDA K,KITANO S.Laparoscopic gastrectomy with lymph node dissection for gastric cancer[J].Gastric Cancer,2006,9(3):167-176.
[2] JAPANESE GASTRIC CANCER ASSOCIATION.Japanese gastric cancer treatment guidelines 2010(ver.3)[J].Gastric Cancer,2011,14(2):113-123.
[3] ISHIKAWA K,YASUDA K,SHIROMIZU A,et al.Laparoscopic sentinel node navigation achieved by infrared ray electronic endoscopy system in patients with gastric cancer[J].Surg Endosc,2007,21(7):1131-1134.
[4] CABANAS R M.An approach for the treatment of penile carcinoma[J].Cancer,1977,39(2):456-466.
[5] CREW K D,NEUGUT A I.Epidemiology of gastric cancer[J].World J Gastroenterol,2006,12(3):354-362.
[6] KUNISAKI C,AKIYAMA H,NOMURA M,et al.Significance of long-term follow-up of early gastric cancer[J].Ann Surg Oncol,2006,13(3):363-369.
[7] CHIKARA K,HIROSHI S,MASATO N,et al.Association of thenumber of metastaic perigastric lymph nodes with long-term survival in gastric cancer[J].Hepatogastroenterology,2005,52(61):277-280.
[8] ALATENGBAOLIDE M,LIN D P,LI Y M,et al.Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph node[J].Am J Clin Oncol,2013,36(4):325-330.
[9] BI Y M,CHEN X Z,JING C K,et al.Safety and survival benefit of surgical management for elderly gastric cancer patients[J].Hepatogastroenterology,2014,61(134):1801-1805.
[10] SAITO H,OSAKI T,MURAKAMI D,et al.Effect of age on prognosis in patients with gastric cancer[J].ANZJ Surg,2006,76(6):458-461.
[11] 季加孚.不断提高我国胃癌规范化治疗水平[J].中华普外科手术学杂志:电子版,2013,7(1):1-3.DOI:10.3877/cma.j.issn.1674-3946.2013.01.001.
[12] PARK S R,LEE J S,KIM C G,et al.Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer[J].Cancer,2008,112(11):2368-2376.
[13] EMMETT M S,SYMONDS K E,RIGBY H,et al.Prediction of melanoma metastasis by the Shields index based on lymphatic vessel density[J].BMC Cancer,2010,10:208.
[14] SUGA K,YAMAMOTO S,TANGOKU A,et al.Breast sentinel lymphnode navigation with three-dimensional interstitial mutidetector-row computed tomographic lymphography[J].Invest Radiol,2005,40(6):336-342.
[15] NICHOLLS S C,HOFFER E K,CHANDLER W L.Failure of peripheral arterial thrombolysis due to elevated plasminogen activator inhibitor type 1[J].Blood Coagul Fibrinolysis,2003,14(8):729-733.
[16] MORITA D,TSUDA H,ICHIKURA T,et al.Analysis of sentinelnode involvement in gastric cancer[J].Clin Gastroenterol Hepatol,2007,5(9):1046-1052.
[17] ICHIKURA T,SUGASAWA H,SAKAMOTO N,et al.Limitedgastrectomy with dissection of sentinel node stations for early gastric cancer with negative sentinel node biopsy[J].Ann Surg,2009,249(6):942-947.

相似文献/References:

[1]陈赜,陈杰,严想元,等.腹腔镜辅助胃癌根治术治疗早期胃癌疗效观察[J].新乡医学院学报,,():000.
[2]于成功,萧树东,赵宪邨,等.胃癌胃良性病变患者血清和局部组织中IL—I水平及意义[J].新乡医学院学报,1996,13(03):220.
[3]王淑秀,赵卫星,和瑞芝,等.P~(53)和rasP~(21)在胃癌中表达的免疫组化研究[J].新乡医学院学报,1997,14(02):137.
[4]赵卫星,王淑秀,卢朝晖,等.幽门螺杆菌与胃癌基因抑癌基因突变的关系[J].新乡医学院学报,1997,14(03):203.
[5]王淑秀.抑癌基因和癌基因与胃癌[J].新乡医学院学报,1997,14(01):083.
[6]冯艳玲,乐晓萍,蔡新华.胃癌患者P16和P53蛋白的表达及其相互关系[J].新乡医学院学报,2000,17(06):403.
[7]周玲生.纤维胃镜粘膜活检1356 例病理分析[J].新乡医学院学报,2000,17(06):462.
[8]任金萍,王淑秀,付华民,等.青年与老年人胃癌中PCNA和AgNOR计数表达的对比研究[J].新乡医学院学报,2000,17(03):156.
[9]贾文英,张合喜,马彦民.幽门螺杆菌感染与胃癌关系的Meta 分析[J].新乡医学院学报,2000,17(05):328.
[10]窦天伟,刘 炯,罗志勇,等.复发胃癌再次手术42例疗效和随访结果[J].新乡医学院学报,2003,20(05):337.

更新日期/Last Update: 2017-04-05